1. Home
  2. CRUS vs PTCT Comparison

CRUS vs PTCT Comparison

Compare CRUS & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cirrus Logic Inc.

CRUS

Cirrus Logic Inc.

HOLD

Current Price

$144.29

Market Cap

5.9B

Sector

Technology

ML Signal

HOLD

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

HOLD

Current Price

$69.35

Market Cap

6.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRUS
PTCT
Founded
1984
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.9B
6.1B
IPO Year
1989
2013

Fundamental Metrics

Financial Performance
Metric
CRUS
PTCT
Price
$144.29
$69.35
Analyst Decision
Strong Buy
Buy
Analyst Count
5
18
Target Price
$147.60
$76.28
AVG Volume (30 Days)
814.5K
1.0M
Earning Date
02-03-2026
02-19-2026
Dividend Yield
N/A
N/A
EPS Growth
37.60
N/A
EPS
7.56
8.94
Revenue
$1,973,312,000.00
$1,779,150,000.00
Revenue This Year
$1.37
$132.16
Revenue Next Year
$2.76
N/A
P/E Ratio
$18.79
$7.91
Revenue Growth
7.04
97.54
52 Week Low
$75.83
$35.95
52 Week High
$146.88
$87.50

Technical Indicators

Market Signals
Indicator
CRUS
PTCT
Relative Strength Index (RSI) 68.02 37.18
Support Level $139.26 $69.75
Resistance Level $146.88 $76.99
Average True Range (ATR) 6.77 2.60
MACD 0.73 -0.44
Stochastic Oscillator 82.83 13.85

Price Performance

Historical Comparison
CRUS
PTCT

About CRUS Cirrus Logic Inc.

Cirrus Logic Inc is a provider of integrated circuits for audio and voice signal processing applications. The firm's products are organized into two streams: portable audio products, and HPMS Products. These products include aAmplifiers, codecs, smart codecs, analog-to-digital converters, digital-to-analog converters and standalone digital signal processors, Camera controllers, haptics and sensing solutions, and battery and power ICs. Roughly half of the firm's revenue is generated in China, with the rest coming from the United States, Europe, South Korea, and countries across the world.

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

Share on Social Networks: